Pulmonary Medicine - Global Oncology Academy

1-16 of 78

The Evolving TROP2-directed ADC Landscape in Metastatic NSCLC
The Evolving TROP2-directed ADC Landscape in Metastatic NSCLC
Oncology and Hematology
The Evolving TROP2-directed ADC Landscape in Metastatic NSCLC
Nicolas Girard, MD; Louise Lim, MD
- Nicolas Girard, MD
- Louise Lim, MD
- Jacob Sands, MD
- Stephanie McDonald, MSN, FNP-BC, AOCNP
6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
Project Oncology®
6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
Steve Jackson, PharmD; Lyudmila A. Bazhenova, MD
- Steve Jackson, PharmD
- Lyudmila A. Bazhenova, MD
Assessing and Interpreting pCR in Perioperative NSCLC
Assessing and Interpreting pCR in Perioperative NSCLC
Project Oncology®
Assessing and Interpreting pCR in Perioperative NSCLC
Steve Jackson, PharmD; Alexander Spira, MD, PhD, FACP
- Steve Jackson, PharmD
- Alexander Spira, MD, PhD, FACP
Key Differences in Pulmonary and Extrapulmonary NEC Management
Key Differences in Pulmonary and Extrapulmonary NEC Management
Project Oncology®
Key Differences in Pulmonary and Extrapulmonary NEC Management
Alexandria May, PharmD, BCPS; Lowell B. Anthony, MD, FACP
- Alexandria May, PharmD, BCPS
- Lowell B. Anthony, MD, FACP
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Project Oncology®
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Deepa Rangachari, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Deepa Rangachari, MD
Communicating Pathologic Response Results in Resectable NSCLC
Communicating Pathologic Response Results in Resectable NSCLC
Project Oncology®
Communicating Pathologic Response Results in Resectable NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Alexander Spira, MD, PhD, FACP
- Charles Turck, PharmD, BCPS, BCCCP
- Alexander Spira, MD, PhD, FACP
- Robert Merritt, MD
Managing High-Risk Subgroups in Metastatic NSCLC
Managing High-Risk Subgroups in Metastatic NSCLC
Project Oncology®
Managing High-Risk Subgroups in Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Melina Marmarelis, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Melina Marmarelis, MD
- Deepa Rangachari, MD
Managing Immune-Related Adverse Events in Metastatic NSCLC
Managing Immune-Related Adverse Events in Metastatic NSCLC
Project Oncology®
Managing Immune-Related Adverse Events in Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Paul Bunn, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Paul Bunn, MD
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Project Oncology®
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Charles Turck, PharmD, BCPS, BCCCP; Laura Alder, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Laura Alder, MD
- Christine Bestvina, MD
Emerging Therapeutic Strategies in Metastatic NSCLC
Emerging Therapeutic Strategies in Metastatic NSCLC
Project Oncology®
Emerging Therapeutic Strategies in Metastatic NSCLC
Brian P. McDonough, MD, FAAFP; Urs Weber, MD
- Brian P. McDonough, MD, FAAFP
- Urs Weber, MD
Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
COVID-19: On The Frontlines
Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
Hallie Blevins, PhD; Marlene Mimi Maeusli, PhD.
- Hallie Blevins, PhD
- Marlene Mimi Maeusli, PhD.
Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Project Oncology®
Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Steve Jackson, PharmD; Raghava Reddy Induru, MD
- Steve Jackson, PharmD
- Raghava Reddy Induru, MD
Optimizing Multidisciplinary Care in Perioperative NSCLC
Optimizing Multidisciplinary Care in Perioperative NSCLC
Project Oncology®
Optimizing Multidisciplinary Care in Perioperative NSCLC
Steve Jackson, PharmD; David Tom Cooke, MD, FACS
- Steve Jackson, PharmD
- David Tom Cooke, MD, FACS
- Joshua Reuss, MD
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Project Oncology®
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Raghava Reddy Induru, MD
- Raghava Reddy Induru, MD
Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Project Oncology®
Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Raghava Reddy Induru, MD
- Raghava Reddy Induru, MD
Managing Brain Metastases in ALK+ NSCLC
Managing Brain Metastases in ALK+ NSCLC
Project Oncology®
Managing Brain Metastases in ALK+ NSCLC

Prev
1
2
3
4
5
Next

1/5